Networks exist in both nature—such as biological systems like food webs and gene regulatory networks—and in engineered ...

Tools like CRISPR-Cas9 are creating new opportunities for innovation in St. Louis, as well as risks around IP protection and regulation.

Cibus, Inc. (Nasdaq: CBUS) (the 'Company'), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced its financial results for the quarter ...

I'd like to thank you for taking time to join us for Cibus' Fourth Quarter 2025 Financial Results and Business ...

Peer-reviewed study demonstrates tumor-eradicating activity and durable anti-tumor immunity in multiple preclinical solid tumor models ...

NEW YORK and SAN SEBASTIÁN, Spain, March 17, 2026 /PRNewswire/ -- Apertura Gene Therapy, a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, and ...

Wall Street Journal takes three weeks to correct false sexual harassment report, days before FDA commissioner said targeted official was leaving.

First ZEVASKYN® commercial patient treatment completed in December -- ZEVASKYN launch momentum building in first quarter 2026 –- $191.4M in ...

The FDA's embattled vaccine chief, Vinay Prasad, will exit the agency. But that doesn't mean biotech stocks should breathe ...

Terumo Blood and Cell Technologies has entered a new collaboration with Taiwan Bio Therapeutics to transition regulatory T‑cell manufacturing onto the automated Quantum Flex platform, marking a shift ...

The new F1 regulations have divided opinion: some think the racing is now like Mario Kart, but Leclerc is relishing the challenge ...